Dentsply Sirona rises after prelim second-quarter revenue tops estimates

DENTSPLY SIRONA

21/07/2025 15:27

** Shares of dental products maker Dentsply Sirona XRAY.O rise 3.1% to $16.16

** Co posts Q2 prelim revenue of $935 million, surpassing analysts' average estimate of $933.1 million, according to data compiled by LSEG

** XRAY appoints Daniel Scavilla as CEO, effective August 1

** Adjusted EPS for Q2 2025 expected between $0.50 and $0.52, vs. est of $0.50

** Including session's move, XRAY stock down 15% YTD

 (Reporting by Padmanabhan Ananthan)

 ((Padmanabhan.Ananthan@thomsonreuters.com))